Optimization of 1,4-Naphthoquinone Hit Compound: A Computational, Phenotypic, and In Vivo Screening against <i>Trypanosoma cruzi</i>
Chagas disease (CD) still represents a serious public health problem in Latin America, even after more than 100 years of its discovery. Clinical treatments (nifurtimox and benznidazole) are considered inadequate, especially because of undesirable side effects and low efficacy in the chronic stages o...
Main Authors: | Leonardo S. Lara, Guilherme C. Lechuga, Caroline dos S. Moreira, Thaís B. Santos, Vitor F. Ferreira, David R. da Rocha, Mirian C. S. Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/2/423 |
Similar Items
-
Avaliação da atividade anti-trypanosoma cruzi in vitro e in vivo de derivados de vitamina K
by: Castro, Murilo Fagundes de
Published: (2013) -
Evaluation of some organic compounds on bloodstream forms of Trypanosoma cruzi
by: João S. Silva, et al.
Published: (1992-09-01) -
The Trypanocidal Activity of Naphthoquinones: A Review
by: Solange Lisboa de Castro, et al.
Published: (2009-11-01) -
Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
by: Angela Maria Lourenço, et al. -
Trypanocidal activity of isolated naphthoquinones from Tabebuia and some heterocyclic derivatives: a review from an interdisciplinary study
by: De Moura Kelly C. G., et al.
Published: (2001-01-01)